Spectroscopy In-Depth Focus 2016
Posted: 24 August 2016 | European Pharmaceutical Review | No comments yet
In this Spectroscopy In-Depth Focus: The benefits of NIRS in monitoring and controlling a crystallisation process; Pharmaceutical applications of terahertz spectroscopy and imaging; and much more…
- The benefits of NIRS in monitoring and controlling a crystallisation process
Koen De Smet, Tom Van Den Kerkhof and Anke Prudic, Janssen – Pharmaceutical Companies of Johnson & Johnson - Pharmaceutical applications of terahertz spectroscopy and imaging
Daniel Markl, Michael T. Ruggiero, and J. Axel Zeitler, University of Cambridge - Expert View
Sponsored by Viavi Solutions - Spectroscopy Q&A
With Rob Morris, Marketing Manager of Ocean Optics - Expert View
Sponsored by Tornado Spectral Systems
This Spectroscopy In-Depth Focus is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- bi-monthly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Issue
Related topics
Related organisations
Johnson & Johnson, Ocean Optics, Tornado Spectral Systems, University of Cambridge, Viavi
Related people
Anke Prudic, Daniel Markl, J. Axel Zeitler, Koen De Smet, Michael T. Ruggiero, Tom Van den Kerkhof
